Vasculitis Pregnancy Registry
NCT02593565 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-01-23
Summary
The purpose of this study is to learn about the experience of women with vasculitis who become pregnant. In particular, the study will consist of several online surveys to assess
1. each woman's vasculitis severity and pregnancy-related experiences, and
2. pregnancy outcomes.
Conditions
- Vasculitis
- Behcet's Disease
- CNS Vasculitis
- Cryoglobulinemic Vasculitis
- Eosinophilic Granulomatosis With Polyangiitis (EGPA)
- Churg-Strauss Syndrome (CSS)
- Granulomatosis With Polyangiitis (GPA)
- Wegener's Granulomatosis
- IgA Vasculitis
- Henoch-Schoenlein Purpura (HSP)
- Microscopic Polyangiitis (MPA)
- Polyarteritis Nodosa (PAN)
- Takayasu Arteritis (TAK)
- Urticarial Vasculitis
- Systemic Vasculitis
Interventions
- OTHER
-
Online questionnaires
Women will be asked to complete questionnaires during their pregnancy and a postpartum questionnaire.
Sponsors & Collaborators
- collaborator OTHER
-
University of South Florida
collaborator OTHER - lead OTHER
Principal Investigators
-
Megan Clowse, MD, MPH · Duke University
-
Peter A Merkel, MD, MPH · University of Pennsylvania
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-11-30
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- United States
Study Locations
More Related Trials
-
Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
NCT00315393 ·Status: COMPLETED
-
Apremilast Pregnancy Exposure Registry
NCT02775500 ·Status: ACTIVE_NOT_RECRUITING
-
The ANCA Vasculitis Questionnaire (AAV-PRO©)
NCT02507024 ·Status: COMPLETED
-
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)
NCT01862068 ·Status: COMPLETED
-
Educational Needs of Patients With Systemic Vasculitis
NCT02190929 ·Status: COMPLETED
-
Vasculitis Illness Perception (VIP) Study
NCT02190916 ·Status: COMPLETED
-
Intravenous Immunoglobulin After Relapse in Vasculitis
NCT00307658 ·Status: TERMINATED ·Phase: PHASE3
-
VCRC Tissue Repository
NCT02967068 ·Status: RECRUITING
-
Immunity Against AAV in Crigler Najjar Patient
NCT02302690 ·Status: COMPLETED
-
Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
NCT00307671 ·Status: COMPLETED ·Phase: PHASE4
-
Steroids and Methotrexate to Treat Systemic Vasculitis
NCT00001256 ·Status: COMPLETED ·Phase: PHASE2
-
Autoimmune and Autoinflammatory Genetics Study
NCT06004349 ·Status: RECRUITING
-
Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
NCT02556866 ·Status: TERMINATED ·Phase: PHASE2
-
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
NCT00059748 ·Status: RECRUITING
-
Hematopoietic Stem Cell Support in Vasculitis
NCT00278512 ·Status: TERMINATED ·Phase: PHASE1
-
Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis
NCT06940661 ·Status: RECRUITING ·Phase: PHASE2
-
Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)
NCT00647166 ·Status: COMPLETED ·Phase: PHASE3
-
Plasmapheresis Before Rituximab in Cryoglobulinemia
NCT04692363 ·Status: UNKNOWN
-
Biocollection of Patients With ANCA Associated Vasculitis
NCT05364892 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome
NCT00716651 ·Status: COMPLETED ·Phase: PHASE2
-
Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)
NCT00103792 ·Status: COMPLETED ·Phase: PHASE3
-
PRO Development for ANCA Associated Vasculitis
NCT01729624 ·Status: UNKNOWN
-
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
NCT05329090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Identification of Biomarkers Predictive of Worse Prognosis in Henoch Schonlein Purpura
NCT01610830 ·Status: UNKNOWN
-
Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides
NCT00001473 ·Status: COMPLETED